The global demand for Technetium-99m Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026. Whereas with regards to volume, the market was calculated XX KT in 2019 and foreseen to touch XX KT by 2026 with a CAGR of XX% during 2020-2026.
Technetium-99m is a silver-grey radioactive metal. It is a pure gamma emitter widely used in nuclear medicine. Technetium-99m is mainly extracted for medical purposes from the fission products created in neutron-irradiated U-235 targets, the majority of which is produced in five nuclear research reactors around the world using highly enriched uranium targets.
Majority of Tc-99 is consumed by the United States, accounting for 50 per cent of all procedures that utilize Tc-99m. Globally, approximately 40,000-50,000 procedures use Tc-99 daily. Myocardial perfusion imaging for coronary artery disease dominates the overall demand for Technetium-99m owing to the high prevalence of coronary artery disease and the relatively large amounts of Tc-99m needed to image for the disease. The market is facing a shortage of the past five years. Factors contributed to the decline,include, increased preference for competing for imaging modalities, changes in medical insurance reimbursement policies, and radiation exposure concerns.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Technetium-99m.
The entire Technetium-99m market has been sub-categorized into application, and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By End User
- Gamma Camera
- Single Photon Emission Computed Tomography [SPECT]
- Diagnostic Centers
This section covers regional segmentation which accentuates on current and future demand for Technetium-99m market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Technetium-99m Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Technetium-99m market include GE Healthcare, Lantheus Medical Imaging, Inc., Curium, Siemens Healthineers, Advanced Accelerator Applications. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.